Volume 21, Issue 126 (12-2014)                   RJMS 2014, 21(126): 83-90 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Zabihiyeganeh M. Pregnancy and Rheumatic diseases. RJMS. 2014; 21 (126) :83-90
URL: http://rjms.iums.ac.ir/article-1-3432-en.html
Iran University of Medical Sciences, Tehran, Iran
Abstract:   (2443 Views)
Pregnancy could be a challenge for physicians managing women with rheumatic diseases. Many of these diseases affect women of child-bearing age. Awareness of safe drugs, pregnancy effects on disease, and the effect of pregnancy are vitally important. For better results a group consisted of a gynecologist and internal physician should work together to these women. In general, active inflammation from rheumatic diseases immunosuppressant medications pose threat to health of both mother and fetus. In recent years availability of biologic therapies for treating resistant rheumatic diseases has created a great challenge concerning their safety during pregnancy and breastfeeding. During this study, we reviewed treatment of the most common rheumatic diseases including Rheumatoid Arthritis, Systemic Lupus Erythematous and Antiphospholipid syndrome. Prior, during and after pregnancy, the most relevant issues regarding medications will be discussed.
Full-Text [PDF 194 kb]   (7842 Downloads)    
Type of Study: review article | Subject: Rheumatology

Add your comments about this article : Your username or Email:
CAPTCHA code

© 2018 All Rights Reserved | Razi Journal of Medical Sciences

Designed & Developed by : Yektaweb